The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Natural history of chronic hepatitis C
Open accessAbstract
Much controversy surrounds the issue of the natural history of hepatitis C virus (HCV) infection. Many authorities view the disease as inexorably progressive with a high probability of advancing over time to cirrhosis and occasionally hepatocellular carcinoma (HCC) and, therefore, likely to be responsible for causing death. Others regard chronic hepatitis C as having a variable outcome, the majority of infected persons not dying from the disease, but more likely from the comorbid conditions that so often accompany infection by this agent, or from more common medical conditions. Disagreements probably derive from the manner of conduct of the study and the populations studied. Efforts to determine natural history are handicapped by the primary characteristics of the disease, namely that its onset rarely is recognized and its course is prolonged exceedingly. Thus, different outcomes have come from retrospective rather than from prospective studies, but both have concluded that at least 20% of chronically infected adults develop cirrhosis within 20 years. More recent studies that used a retrospective/prospective approach, focusing largely on young infected individuals, have produced different results. Among these young people, particularly young women, spontaneous resolution of the viral infection is more common than previously thought and cirrhosis has been identified in 5% or fewer of them. The major failing for all groups studied, young and old, is that natural history studies have rarely exceeded the first 2 decades, so that outcome beyond this time is not known, other than through modeling. Several host-related and extraneous factors probably affect the natural history.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Zeuzem, S., Feinman, S. V., Rasenack, J., Heathcote, E. J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Diago, M., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432301 · Cited by 1,220
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P., Katlama, C., et al. (1999) · Hepatology · doi:10.1002/hep.510300409 · Cited by 1,219
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J., Balestrieri, A., et al. (2000) · Science · doi:10.1126/science.288.5464.339 · Cited by 884
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868
Self-citationSignificance of serum hepatitis C virus RNA levels in chronic hepatitis C
Lau, J. Y. N., Davis, G. L., Kniffen, J., Qian, K.-P., Urdea, M. S., Chan, C. S., Neuwald, P. D., Wilber, J. C., & Mizokami, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)90635-t · Cited by 795
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. H., Shorthouse, C., Clouston, A., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510290401 · Cited by 674
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Self-citationAssociation of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, F. G., Zimmerman, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290235 · Cited by 659
Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort Study
Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hürter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W., et al. (1998) · Hepatology · doi:10.1002/hep.510280632 · Cited by 636
Estimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 598
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Vogt, M. O., Lang, T., Frösner, G., Klingler, C., Sendl, A., Zeller, A., Wiebecke, B., Langer, B., Meisner, H., & Hess, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411202 · Cited by 502
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
Villano, S. A., Vlahov, D., Nelson, K. E., Cohn, S., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290311 · Cited by 475
Impact of alcohol on the histological and clinical progression of Hepatitis C infection
Wiley, T. E., McCarthy, M., Breidi, L., McCarthy, M., & Layden, T. J. (1998) · Hepatology · doi:10.1002/hep.510280330 · Cited by 436
Host genetic factors influence disease progression in chronic hepatitis C
Powell, E. E., Edwards-Smith, C. J., Hay, J. L., Clouston, A. D., Crawford, D. H., Shorthouse, C., Purdie, D. M., & Jonsson, J. R. (2000) · Hepatology · doi:10.1053/he.2000.6253 · Cited by 398
Bonkovsky, H. L., & Woolley, M. J. (1999) · Hepatology · doi:10.1002/hep.510290124 · Cited by 398
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults
Seeff, L. B., Miller, R. N., Rabkin, C. S., Buskell-Bales, Z., Straley-Eason, K. D., Smoak, B. L., Johnson, L. D., Lee, S. R., & Kaplan, E. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00003 · Cited by 347
Self-citationPessione, F., Degos, F., Marcellin, P., Duchatelle, V., Njapoum, C., Martinot-Peignoux, M., Degott, C., Valla, D., Erlinger, S., & Rueff, B. (1998) · Hepatology · doi:10.1002/hep.510270635 · Cited by 340
Iron and Chronic Viral Hepatitis
Bonkovsky, H. L., Banner, B. F., & Rothman, A. L. (1997) · Hepatology · doi:10.1002/hep.510250345 · Cited by 335
Di Martino, V., Rufat, P., Boyer, N., Renard, P., Degos, F., Martinot-Peignoux, M., Matheron, S., Le Moing, V., Vachon, F., Degott, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.29201 · Cited by 335
Corrao, G., & Aricò, S. (1998) · Hepatology · doi:10.1002/hep.510270404 · Cited by 324
Seeff, L. B., Hollinger, B. F., Alter, H. J., Wright, E. C., Cain, C. M. B., Buskell, Z. J., Ishak, K. G., Iber, F. L., Toro, D., Samanta, A., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.21905 · Cited by 321
Self-citationMathurin, P., Moussalli, J., Cadranel, J.-F., Thibault, V., Charlotte, F., Dumouchel, P., Cazier, A., Huraux, J.-M., Devergie, B., Vidaud, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270333 · Cited by 302
The impact of diagnosis of hepatitis C virus on quality of life
Rodger, A. J., Jolley, D., Thompson, S. C., Lanigan, A., & Crofts, N. (1999) · Hepatology · doi:10.1002/hep.510300504 · Cited by 298
Racial differences in responses to therapy with interferon in chronic hepatitis C
Reddy, R. K., Hoofnagle, J. H., Tong, M. J., Lee, W. M., Pockros, P., Heathcote, J. E., Albert, D., & Joh, T. (1999) · Hepatology · doi:10.1002/hep.510300319 · Cited by 291
Role of alcohol in the progression of liver disease caused by hepatitis C virus infection
Ostapowicz, G., Watson, K. J., Locarnini, S. A., & Desmond, P. V. (1998) · Hepatology · doi:10.1002/hep.510270637 · Cited by 286
Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis
Tremolada, F., Casarin, C., Alberti, A., Drago, C., Tagger, A., Ribero, M. L., & Realdi, G. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80657-9 · Cited by 263
Olynyk, J. K., Reddy, K. R., di Bisceglie, A. M., Jeffers, L. J., Parker, T. I., Radick, J. L., Schiff, E. R., & Bacon, B. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90209-0 · Cited by 254
Silini, E., Bono, F., Cividini, A., Cerino, A., Bruno, S., Rossi, S., Belloni, G., Brugnetti, B., Civardi, E., Salvaneschi, L., et al. (1995) · Hepatology · doi:10.1002/hep.1840210204 · Cited by 252
Puoti, C., Magrini, A., Stati, T., Rigato, P., Montagnese, F., Rossi, P., Aldegheri, L., & Resta, S. (1997) · Hepatology · doi:10.1002/hep.510260603 · Cited by 234
Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade
Koretz, R. L., Abbey, H., Coleman, E., & Gitnick, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00003 · Cited by 233
Alric, L., Fort, M., Izopet, J., Vinel, J., Charlet, J., Selves, J., Puel, J., Pascal, J., Duffaut, M., & Abbal, M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9352872 · Cited by 220
Lesens, O., Deschênes, M., Steben, M., Bélanger, G., & Tsoukas, C. M. (1999) · The Journal of Infectious Diseases · doi:10.1086/314720 · Cited by 218
Kobayashi, M., Tanaka, E., Sodeyama, T., Urushihara, A., Matsumoto, A., & Kiyosawa, K. (1996) · Hepatology · doi:10.1002/hep.510230406 · Cited by 213
Modeling the Hepatitis C Virus Epidemic in France
Deuffic, S., Buffat, L., Poynard, T., & Valleron, A.-J. (1999) · Hepatology · doi:10.1002/hep.510290528 · Cited by 210
Response to interferon α therapy is influenced by the iron content of the liver
Van Thiel, D. H., Friedlander, L., Fagiuoli, S., Wright, H. I., Irish, W., & Gavaler, J. S. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80017-0 · Cited by 209
Cigarette Smoking and Hepatic Lesions in Patients With Chronic Hepatitis C
Pessione, F., Ramond, M.-J., Njapoum, C., Duchatelle, V., Degott, C., Erlinger, S., Rueff, B., Valla, D.-C., & Degos, F. (2001) · Hepatology · doi:10.1053/jhep.2001.25385 · Cited by 207
Smith, B. C., Grove, J., Guzail, M. A., Day, C. P., Daly, A. K., Burt, A. D., & Bassendine, M. F. (1998) · Hepatology · doi:10.1002/hep.510270631 · Cited by 203
Harris, D. R., Gonin, R., Alter, H. J., Wright, E. C., Buskell, Z. J., Hollinger, F. B., Seeff, L. B., & for the National Heart, L. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00012 · Cited by 194
Self-citationRagni, M. V., & Belle, S. H. (2001) · The Journal of Infectious Diseases · doi:10.1086/319273 · Cited by 194
Rodger, A. J., Roberts, S., Lanigan, A., Bowden, S., Brown, T., & Crofts, N. (2000) · Hepatology · doi:10.1053/jhep.2000.9714 · Cited by 182
Diabetes increases the risk of acute hepatic failure
El–Serag, H. B., & Everhart, J. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.33650 · Cited by 174
Hepatitis C infection in African Americans: its natural history and histological progression
Wiley, T. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04117-x · Cited by 169
Peters, M. G., & Terrault, N. A. (2002) · Hepatology · doi:10.1053/jhep.2002.36811 · Cited by 166
Di Bisceglie, A. M., Bonkovsky, H. L., Chopra, S., Flamm, S., Reddy, R. K., Grace, N., Killenberg, P., Hunt, C., Tamburro, C., Tavill, A. S., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.8700 · Cited by 163
Chronic hepatitis C and superimposed nonalcoholic fatty liver disease
Ong, J. P., Younossi, Z. M., Speer, C. A., Olano, A., Gramlich, T., & Boparai, N. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.021004266.x · Cited by 151
Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus
Major, M. E., Mihalik, K., Fernandez, J., Seidman, J. C., Kleiner, D. E., Kolykhalov, A. A., Rice, C. M., & Feinstone, S. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3317-3325.1999 · Cited by 149
Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus
Kuzushita, N., Hayashi, N., Moribe∥, T., Katayama, K., Kanto, T., Nakatani, S., Kaneshige, T., Tatsumi, T., Ito, A., Mochizuki, K., et al. (1998) · Hepatology · doi:10.1002/hep.510270136 · Cited by 145
Mori, M., Hara, M., Wada, I., Hara, T., Yamamoto, K., Honda, M., & Naramoto, J. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010180 · Cited by 144
Hepatitis C and human immunodeficiency virus infection
Thomas, D. L. (2002) · Hepatology · doi:10.1053/jhep.2002.36380 · Cited by 144
Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus
Minton, E. J., Smillie, D., Neal, K. R., Irving, W. L., Underwood, J. C. E., James, V., & Members of the Trent Hepatitis C Virus Study Group (1998) · The Journal of Infectious Diseases · doi:10.1086/515599 · Cited by 137
Gordon, S. C., Elloway, R. S., Long, J. C., & Dmuchowski, C. (1993) · Hepatology · doi:10.1002/hep.1840180609 · Cited by 132
The Provincial Group for the Study of Chronic Liver Disease, Corrao, G., Lepore, A. R., Torchio, P., Valenti, M., GALATOLA, G., D’Amicis, A., Aricò, S., & di Orio, F. (1994) · European Journal of Epidemiology · doi:10.1007/bf01719277 · Cited by 132
Clinical outcome of hepatitis C as a function of mode of transmission
Gordon, S. C., Bayati, N., & Silverman, A. L. (1998) · Hepatology · doi:10.1002/hep.510280238 · Cited by 131
Hepatitis C in African Americans: Summary of a workshop
Howell, C. D., Jeffers, L. J., & Hoofnagle, J. H. (2000) · Gastroenterology · doi:10.1053/gast.2000.19582 · Cited by 127
Kanzler, S., Baumann, M., Schirmacher, P., Dries, V., Bayer, E., Gerken, G., Dienes, H. P., & Lohse, A. W. (2001) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2001.00314.x · Cited by 121
Bissell, M. D. (1999) · Hepatology · doi:10.1002/hep.510290351 · Cited by 116
Hussain, K. B. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02695-8 · Cited by 114
Mattsson, L., Sönnerborg, A. B., & Weiland, O. (1993) · Liver International · doi:10.1111/j.1600-0676.1993.tb00644.x · Cited by 108
Zavaglia, C., Martinetti, M., Silini, E. M., Bottelli, R., Daielli, C., Asti, M., Airoldi, A., Salvaneschi, L., Mondelli, M. U., & Ideo, G. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80195-5 · Cited by 103
Iron overload in patients with chronic hepatitis C: A clinicopathologic study
HAQUE, S. M. N., Chandra, B., Gerber, M. A., & Lok, A. S.-F. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90337-8 · Cited by 99
Effects of Iron Loading on Pathogenicity in Hepatitis C Virus-Infected Chimpanzees
Bassett, S. E., Bisceglie, A. M. D., Bacon, B. R., Sharp, R. M., Govindarajan, S., Hubbard, G. B., Brasky, K. M., & Lanford, R. E. (1999) · Hepatology · doi:10.1002/hep.510290623 · Cited by 87
HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients
Roffi, L., Ricci, A., Ogliari, C., Scalori, A., Minola, E., Colloredo, G., Donada, C., Ceriani, R., Rinaldi, G., Paris, B., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80249-3 · Cited by 81
Progression of fibrosis in chronic liver diseases: time to tally the score
Pinzani, M., Romanelli, R. G., & Magli, S. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00055-1 · Cited by 70
Coinfection by hepatitis B virus and hepatitis C virus.
Pontisso, P., Gerotto, M., Benvegnù, L., Chemello, L., & Alberti, A. (1998) · PubMed · Cited by 63
Chronic Liver Disease in Central Harlem: the Role of Alcohol and Viral Hepatitis
Frieden, T. R., Ozick, L. A., MCCORD, C. W., Nainan, O. V., Workman, S., Comer, G. M., Lee, T. P., Byun, K.-S., Patel, D. R., & Henning, K. J. (1999) · Hepatology · doi:10.1002/hep.510290308 · Cited by 56
Mukaiya, M., Nishi, M., Miyake, H., & Hirata, K. (1998) · PubMed · Cited by 53
Tsai, J., Jeng, J., Ho, M., Chang, W., Lin, Z., & Tsai, J. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80004-3 · Cited by 51
The Natural History of Hepatitis C—A Quandary
Seeff, L. B. (1998) · Hepatology · doi:10.1002/hep.510280636 · Cited by 46
Self-citationArber, N., Moshkowitz, M., Konikoff, F. M., Halpern, Z., Hallak, A., Santo, M., Tiomny, E., Baratz, M., & Gilat, T. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02063249 · Cited by 34
Why is there such difficulty in defining the natural history of hepatitis C?
Seeff, L. B. (2000) · Transfusion · doi:10.1046/j.1537-2995.2000.40101161.x · Cited by 27
Self-citation19 Hepatitis C virus infection and alcohol
Everhart, J. E., & Herion, D. W. (2000) · Biomedical research reports · doi:10.1016/s1874-5326(00)80023-x · Cited by 11
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Self-citationGenetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Course and outcome of hepatitis C
Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360704 · Cited by 1,084
Metadata
- Authors
- Seeff, L. B.
- Venue
- Hepatology
- Published
- 2002-11
- Volume
- 36
- Issue
- 5 Suppl 1
- Pages
- s35-s46
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2043976325
- Cited by
- 1,424
- References
- 86
- FWCI
- 36.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.